ArticleCurrent cardiology reviews2026

Cost-Effectiveness of Empagliflozin in Patients with Chronic Heart Failure and Chronic Kidney Disease: A Systematic Review.

Sultanbaeva Nargiza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.